Literature DB >> 8450054

Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema.

J Kramer1, F S Rosen, H R Colten, K Rajczy, R C Strunk.   

Abstract

To ascertain the mechanism for decreased synthesis of C1 inhibitor (C1 INH) in certain patients with the autosomal dominant disorder hereditary angioneurotic edema, we studied expression of C1 INH in fibroblasts in which the mutant and wild type mRNA and protein could be distinguished because of deletion of exon 7 (delta Ex7). In the HANE delta Ex7 cells, the amount of wild type mRNA (2.1 kb) was expressed at 52 +/- 2% (n = 5) of normal, whereas the mutant mRNA was 17 +/- 1% (n = 5) of normal. Rates of synthesis of both wild type and mutant proteins (11 +/- 3 and 3 +/- 1% of normal, respectively) were lower than predicted from the mRNA levels. There was no evidence of increased C1 INH protein catabolism. These data indicate that there are multiple levels of control of C1 INH synthesis in type I hereditary angioneurotic edema. Pretranslational regulation results in < 50% of the mutant truncated 1.9-kb mRNA. In addition, translational regulation results in decreased synthesis of both wild type and mutatn C1 INH proteins. These data suggest a transinhibition of wild type C1 INH translation by mutant mRNA and/or protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450054      PMCID: PMC288087          DOI: 10.1172/JCI116290

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  Recombinations between Alu repeat sequences that result in partial deletions within the C1 inhibitor gene.

Authors:  T Ariga; P E Carter; A E Davis
Journal:  Genomics       Date:  1990-12       Impact factor: 5.736

Review 2.  Molecular basis and prenatal diagnosis of beta-thalassemia.

Authors:  H H Kazazian; C D Boehm
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

3.  Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site.

Authors:  R B Parad; J Kramer; R C Strunk; F S Rosen; A E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 4.  C1 inhibitor and hereditary angioneurotic edema.

Authors:  A E Davis
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

5.  Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema.

Authors:  M Quastel; R Harrison; M Cicardi; C A Alper; F S Rosen
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

6.  Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon.

Authors:  T Ariga; T Igarashi; N Ramesh; R Parad; M Cicardi; A E Davis
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

7.  Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema.

Authors:  M Cicardi; T Igarashi; F S Rosen; A E Davis
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

8.  Tissue-specific pretranslational regulation of complement production in human mononuclear phagocytes.

Authors:  F S Cole; H S Auerbach; G Goldberger; H R Colten
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

9.  Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema.

Authors:  F S Rosen; C A Alper; J Pensky; M R Klemperer; V H Donaldson
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

10.  Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies.

Authors:  V H Donaldson; R A Harrison; F S Rosen; D H Bing; G Kindness; J Canar; C J Wagner; S Awad
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

View more
  12 in total

Review 1.  Angioedema associated with C1 inhibitor deficiency.

Authors:  J Laurent; M T Guinnepain
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

2.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

3.  Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema.

Authors:  Didde Haslund; Laura Barrett Ryø; Sara Seidelin Majidi; Iben Rose; Kristian Alsbjerg Skipper; Tue Fryland; Anja Bille Bohn; Claus Koch; Martin K Thomsen; Yaseelan Palarasah; Thomas J Corydon; Anette Bygum; Lene N Nejsum; Jacob Giehm Mikkelsen
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

Review 4.  HAE Pathophysiology and Underlying Mechanisms.

Authors:  Bruce L Zuraw; Sandra C Christiansen
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

5.  Metabolic alteration of the N-glycan structure of a protein from patients with a heterozygous protein deficiency.

Authors:  Fuming Zhang; Andrew D Bries; Sybil C Lang; Qun Wang; David W Murhammer; John M Weiler; Robert J Linhardt
Journal:  Biochim Biophys Acta       Date:  2004-12-24

Review 6.  Genetics of Hereditary Angioedema Revisited.

Authors:  Anastasios E Germenis; Matthaios Speletas
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 7.  Pathophysiology of Hereditary Angioedema.

Authors:  Sonia Caccia; Chiara Suffritti; Marco Cicardi
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-12-01       Impact factor: 1.349

Review 8.  Navigating the maze of complement genetics: a guide for clinicians.

Authors:  Harvey R Colten
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.919

9.  Angioedema.

Authors:  Allen P Kaplan
Journal:  World Allergy Organ J       Date:  2008-06       Impact factor: 4.084

10.  Expression of the SERPING1 gene is not regulated by promoter hypermethylation in peripheral blood mononuclear cells from patients with hereditary angioedema due to C1-inhibitor deficiency.

Authors:  Alberto López-Lera; Olga Pernia; Margarita López-Trascasa; Inmaculada Ibanez de Caceres
Journal:  Orphanet J Rare Dis       Date:  2014-07-22       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.